Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention

Circulation - United States
doi 10.1161/01.cir.100.19.1977

Related search